Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

CASI CASI Pharmaceuticals, Inc. Ordinary Shares
$0.78 0.00% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy CASI stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 15.6M
Enterprise value 29.9M
Trailing PE -0.29570313636214
Forward PE -0.35920185
PEG Ratio -0.013553060416598
Enterprise to EBITDA -0.707
Enterprise to revenue 1.113
Price to book MRQ -0.42492083323404
Price to sales TTM 0.58561736

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter (MRQ) 2025-09-30
Revenue (TTM) 26.8M
EBITDA -42272500
Diluted EPS TTM -3.02
Total Cash (MRQ) 4.7M
Current ratio (MRQ) 0.302
Operating Cash Flow (TTM) -36715000

CASI trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent CASI News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.